News

Formulated with the company’s proprietary vitamin E-based Tocosol technology, Tocosol Camptothecin is a new chemical entity that is a conjugate of SN-38. SN-38 is the active ingredient in

The companies also announced that Xoma has successfully completed the Human Engineering of AV-299. This agreement further strengthens the collaboration between the companies that began with the humanization

The initial phase Ib trial will evaluate NOV-205 versus placebo as monotherapy in 30 chronic hepatitis C genotype 1 patients who previously failed treatment with pegylated interferon plus

The typical EMEA review period for this centralized procedure is approximately 12 months. In conjunction with this filing, the company has also announced its intent to seek a

Orphan drug designation is intended to encourage research and development into new therapies for rare diseases. Orphan drug designation also provides eligibility for a special seven-year period of

The company said that its retail business was on track with continued expansion in the international and UK community pharmacy businesses. Good weather in July and a particularly

Adherex commented that as 5-FU is one of the most commonly prescribed anti agents in the world, it expected the combination of eniluracil + 5-FU to be rapidly

Under the terms of the agreement, Millennium will commence within ten days a cash tender offer to acquire the shares of AnorMed stock at a price of $12

In the phase III clinical trial, eight out of 10 patients receiving Remicade induction therapy achieved 75% improvement in psoriasis by week 10. Similar results were seen in